Patent Application
Provisional
Small
App. No. 63/341,986
· Confirmation No. 3259
Use of Inhaled Nitric Oxide for Decreasing Pulmonary Arterial Pressure and Pulmonary Vascular Resistance
Applicant:
Bellerophon Therapeutics
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2022-05-24 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2022-05-13 | ADS |
Application Data Sheet | 9 | View | |
| 2022-05-13 | TR.PROV |
Provisional Cover Sheet (SB16) | 3 | View | |
| 2022-05-13 | SPEC |
Specification | 1 | View | |
| 2022-05-13 | CLM |
Claims | 1 | View | |
| 2022-05-13 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2022-05-13 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 28977
- Docket No.
- 111626-5009-PR01
- Confirmation No.
- 3259
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2023-03-29
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 63/341,986
- Filed
- 2022-05-13
External Links